GITLIFE BIOTECH LTD

Active Newcastle Upon Tyne

Research and experimental development on biotechnology

6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
G

GITLIFE BIOTECH LTD

Research and experimental development on biotechnology

Founded 27 Feb 2023 Active Newcastle Upon Tyne, United Kingdom 6 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 13 Jan 2026 Next due 28 May 2027 11 months remaining
Confirmation
Net assets £26K £280K 2025 year on year
Total assets £48K £309K 2025 year on year
Total Liabilities £21K £29K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor Maybrook House 27-35 Grainger Street Newcastle Upon Tyne NE1 5JE United Kingdom

Website

www.example.com

Full company profile for GITLIFE BIOTECH LTD (14690170), an active life sciences and medical technology company based in Newcastle Upon Tyne, United Kingdom. Incorporated 27 Feb 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 29 Aug → 28 Aug 2025
Type total-exemption-full
Next accounts 28 Aug 2026
Due by 28 May 2027 11 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2025)

Cash in Bank

£33.46k

Decreased by £283.26k (-89%)

Net Assets

£26.44k

Decreased by £279.67k (-91%)

Total Liabilities

£21.17k

Decreased by £28.86k (-58%)

Turnover

N/A

Employees

6

Increased by 3 (+100%)

Debt Ratio

44%

Increased by 30 (+214%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Aug Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2024Seed
Investor 2Feb 2024Seed
Investor 3Feb 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 650,375 Shares £125k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Oct 2025110,375£125k£1.13
11 Sept 202525,000£2.5£0
3 Jul 2023515,000£51.5£0

Officers

Officers

2 active 1 resigned
Status
Cambridge Future Tech LtdCorporate-directorUnited KingdomUnknown27 Feb 2023Active
Leanne Winifred HobbsDirectorBritishUnited Kingdom3527 Feb 2023Active

Shareholders

Shareholders (17)

Natalio Krasnogor
31.1%
Newcastle University Holdings Limited
31.1%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Natalio Krasnogor

British

Active
Notified 27 Feb 2023
Residence England
DOB July 1971
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Notified 3 Jul 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

GITLIFE BIOTECH LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Jan 2026AccountsAnnual accounts made up to 28 Aug 2025
10 Oct 2025ResolutionResolutions
10 Oct 2025IncorporationMemorandum Articles
8 Oct 2025CapitalCapital Name Of Class Of Shares
7 Oct 2025OfficersAppointment of Mr Alastair Frederick Archibald Orr Ewing as director on 6 Oct 2025
13 Jan 2026 Accounts

Annual accounts made up to 28 Aug 2025

10 Oct 2025 Resolution

Resolutions

10 Oct 2025 Incorporation

Memorandum Articles

8 Oct 2025 Capital

Capital Name Of Class Of Shares

7 Oct 2025 Officers

Appointment of Mr Alastair Frederick Archibald Orr Ewing as director on 6 Oct 2025

Recent Activity

Latest Activity

Annual accounts made up to 28 Aug 2025

4 months ago on 13 Jan 2026

Resolutions

7 months ago on 10 Oct 2025

Memorandum Articles

7 months ago on 10 Oct 2025

Capital Name Of Class Of Shares

8 months ago on 8 Oct 2025

Appointment of Mr Alastair Frederick Archibald Orr Ewing as director on 6 Oct 2025

8 months ago on 7 Oct 2025